Literature DB >> 26353590

A Titanium Surface-Modified with Nano-Sized Hydroxyapatite and Simvastatin Enhances Bone Formation and Osseintegration.

Yong-Dae Kwon, Dae Hyeok Yang, Deok-Won Lee.   

Abstract

The aim of the present study was to evaluate whether coating pristine titanium (Ti) with nano-sized hydroxyapatite (HAp) and simvastatin could enhance bone formation and osseointegration in vitro and in vivo because both HAp and simvastatin have the characteristic of osteogenetic induction. Pristine Ti was sequentially surface-treated with NaOH, 1,1-carbonyldiimidazole (CDI), beta-cyclodextrin-immobilized HAp powders (β-CD/HAp), and simvastatin before analysis using scanning electron microscopy (SEM), X-ray photoelectron microscopy (XPS), and static contact angle measurement. This revealed that simvastatin was released continually for up 28 days. Modification of the Ti surface with nano-sized HAp and simvastatin (Ti/β-CD/HAp/Sim) discs enhanced the osteogenic differentiation of MC3T3-E1 cells in vitro. Furthermore, Ti/β-CD/HAp/Sim of screw type enhanced bone formation between the screw and the host bone when the screw implanted to the proximal tibia and femoral head of rabbits. These results suggest that surface modification of nano-sized HAp and simvastatin are effective tools for developing attractive dental implants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26353590     DOI: 10.1166/jbn.2015.2039

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  2 in total

Review 1.  [Overview of animal researches about the effects of systemic drugs on implant osseointegration].

Authors:  Ya-Nan Wang; Ting-Ting Jia; Xin Xu; Dong-Jiao Zhang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

2.  Preparation and Evaluation of Dexamethasone (DEX)/Growth and Differentiation Factor-5 (GDF-5) Surface-Modified Titanium Using β-Cyclodextrin-Conjugated Heparin (CD-Hep) for Enhanced Osteogenic Activity In Vitro and In Vivo.

Authors:  Dae Hyeok Yang; Sun-Jung Yoon; Deok-Won Lee
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.